Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Myron David Kor who wrote (3386)	4/16/1998 8:09:00 PM
From: F. Jay Abella, III	Read Replies (3) \| Respond to of 7041

The Oppenheimer rec means that someone there thinks there are transactions to be made on ZONA. Many times, in biotech especially, the "recommendations" are often followed by stock to sell (i.e., an S-3 filing). It has been my experience that s-3's from selling shareholders precede blowups by 3-6 months in the majority of cases. This trick has been employed by NationsBank Montgomery several times, most notably on ALTN and LIPO. Eg ALTN 1/8/98 NB issues buy rec 1/16/98 S-3 filed 3/19/98 stock loses 60% in one day Not saying that this will happen with ZONA. But transactions drive these broker recs, as a rule. FWIW